Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream infections in adults undergoing allogeneic hematopoietic stem ...

CancerBuddy connects users through shared diagnoses and experiences, offering community when hospital walls feel especially confining.

Imminent launch of grant-funded clinical trial in graft-versus-host disease (GVHD)Advancing clinical program in severe pulmonary inflammatory ...

Orca Bio spent the past few years building out a 100,000-square-foot facility in Metro Air Park near the Sacramento International Airport.

UCLA researchers have made strides in developing a stem cell gene therapy for alpha thalassemia major, a severe, inherited ...

The first national, multi-center study to evaluate the full donor search process using a score-based strategy, 1 researchers tested whether the approach could help transplant centers avoid lengthy, ...

Led by former founders of a biotech AstraZeneca acquired in 2023, AllRock Bio is starting out with a drug licensed from ...

Researchers have created a novel immunotherapy for metastatic kidney cancer that could provide a new treatment option for ...

The U.S. Department of Energy's National Nuclear Security Administration has removed Cesium-137 Irradiators from medical ...

Incyte secures FDA nod for Opzeluras pediatric use in atopic dermatitis, marking its third U.S. approval and boosting sales ...

During a live event, Michael R. Bishop, MD, discussed a case of steroid-refractory GVHD and the efficacy and safety outcomes ...